These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 27931047

  • 1. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
    Johns LE, Coleman DA, Swerdlow AJ, Moss SM.
    Br J Cancer; 2017 Jan 17; 116(2):246-252. PubMed ID: 27931047
    [Abstract] [Full Text] [Related]

  • 2. Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women.
    Johns LE, Swerdlow AJ, Moss SM.
    J Med Screen; 2018 Jun 17; 25(2):76-81. PubMed ID: 28675954
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales.
    Waller M, Moss S, Watson J, Møller H.
    Cancer Epidemiol Biomarkers Prev; 2007 Nov 17; 16(11):2257-61. PubMed ID: 18006913
    [Abstract] [Full Text] [Related]

  • 5. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.
    Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ.
    BMJ; 2000 Sep 16; 321(7262):665-9. PubMed ID: 10987769
    [Abstract] [Full Text] [Related]

  • 6. [Tailored Breast Screening Trial (TBST)].
    Paci E, Mantellini P, Giorgi Rossi P, Falini P, Puliti D, TBST Working Group.
    Epidemiol Prev; 2013 Sep 16; 37(4-5):317-27. PubMed ID: 24293498
    [Abstract] [Full Text] [Related]

  • 7. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E.
    APMIS Suppl; 1998 Sep 16; 83():1-44. PubMed ID: 9850674
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
    Hellquist BN, Czene K, Hjälm A, Nyström L, Jonsson H.
    Cancer; 2015 Jan 15; 121(2):251-8. PubMed ID: 25242087
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial.
    Allgood PC, Maroni R, Hudson S, Offman J, Turnbull AE, Peacock L, Steel J, Kirby G, Ingram CE, Somers J, Fuller C, Threlfall AG, Gabe R, Maxwell AJ, Patnick J, Duffy SW.
    Lancet Oncol; 2017 Jul 15; 18(7):972-980. PubMed ID: 28522311
    [Abstract] [Full Text] [Related]

  • 11. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
    Mukhtar TK, Yeates DR, Goldacre MJ.
    J R Soc Med; 2013 Jun 15; 106(6):234-42. PubMed ID: 23761583
    [Abstract] [Full Text] [Related]

  • 12. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
    Duffy SW, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith RA, Evans A, Blyuss O, Johns L, Ellis IO, Myles J, Sasieni PD, Moss SM.
    Lancet Oncol; 2020 Sep 15; 21(9):1165-1172. PubMed ID: 32800099
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of breast screening on breast cancer incidence in England: observational study based on cancer registries and bulletins of the NHS Breast Screening Programme.
    Autier P, Ould Ammar R, Bota M.
    Eur J Public Health; 2024 Aug 01; 34(4):812-817. PubMed ID: 38687973
    [Abstract] [Full Text] [Related]

  • 15. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N, Björneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, Hafström LO, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Säve-Söderbergh J.
    Cancer; 1997 Dec 01; 80(11):2091-9. PubMed ID: 9392331
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    Movik E, Dalsbø TK, Fagelund BC, Friberg EG, Håheim LL, Skår Å.
    ; 2017 09 04. PubMed ID: 29553669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.